このページの翻訳は実験的なもので、現在開発中です。お待ちしております

AnteoTech マネジメント

マネジメント基準チェック /14

AnteoTech'sの CEO はDavid Radfordで、 Oct2022年に任命され、の在任期間は 1.75年です。の年間総報酬はA$ 889.28Kで、 38%給与と62%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.065%を直接所有しており、その価値はA$ 32.08K 。経営陣と取締役会の平均在任期間はそれぞれ2.2年と2.8年です。

主要情報

David Radford

最高経営責任者

AU$997.6k

報酬総額

CEO給与比率	46.9%
CEO在任期間	1.9yrs
CEOの所有権	0.2%
経営陣の平均在職期間	1.9yrs
取締役会の平均在任期間	3yrs

経営陣の近況

Recent updates

CEO報酬分析

AnteoTech の収益と比較して、David Radford の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	AU$998k	AU$468k	-AU$9m
Mar 31 2024	n/a	n/a	-AU$10m
Dec 31 2023	n/a	n/a	-AU$11m
Sep 30 2023	n/a	n/a	-AU$12m
Jun 30 2023	AU$898k	AU$338k	-AU$13m

報酬と市場: Davidの総報酬 ($USD 598.84K ) は、 Australian市場 ($USD 300.74K ) の同規模の企業の平均を上回っています。

報酬と収益: Davidの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

David Radford

1.9yrs

在職期間

AU$997,558

報酬

Mr. David John Radford, BSc (Hons), MBA, MAICD served as Chief Executive Officer of The Hydroponics Company Limited from October 19, 2017 to March 23, 2018. He serves as Managing Director, Chief Executive...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
David Radford	MD, CEO & Executive Director	1.9yrs	AU$997.56k	0.18% A$ 92.9k
Andrew Cook	CFO & Company Secretary	1.1yrs	AU$351.90k	データなし
Katrina Byrne	Chief Operating Officer	1.9yrs	AU$361.18k	データなし
N. Maeji	Founder & Chief Scientific Officer	no data	AU$228.47k	データなし
Manuel Wieser	Chief Technology Officer	no data	データなし	データなし
Tsui Lian	Chief Marketing Officer	1.5yrs	データなし	データなし
Selahattin Guldu	Executive Vice President of Commercial Banking	6.4yrs	データなし	データなし
Ian Steinhardt	Head of Market Operations for Life Sciences	2.8yrs	データなし	データなし
Friederike Graser	Director of Strategic Growth Initiatives	no data	データなし	データなし

1.9yrs

平均在職期間

経験豊富な経営陣: ADOの経営陣は経験豊富とはみなされません ( 1.9年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
David Radford	MD, CEO & Executive Director	1.9yrs	AU$997.56k	0.18% A$ 92.9k
Katherine Woodthorpe	Independent Non-Executive Director & Member of the Energy Advisory Board	3yrs	AU$102.88k	0.032% A$ 16.8k
Glenda McLoughlin	Chair of the Energy Advisory Board & Independent Non-Executive Director	3yrs	AU$105.38k	0.048% A$ 24.9k
Ewen Graham Crouch	Independent Non-Executive Chairman	2.4yrs	AU$155.58k	0.18% A$ 93.2k
Geoffrey Cumming	Member of Clinical Advisory Board & Independent Non-Executive Director	15.4yrs	AU$86.74k	1.06% A$ 551.6k
Paul Young	Member of Clinical Advisory Board	3yrs	データなし	データなし
Oliver Gross	Member of Energy Advisory Board	3yrs	データなし	データなし
Kevin Eberman	Member of Energy Advisory Board	3yrs	データなし	データなし
Dominic Dwyer	Member of Clinical Advisory Board	3yrs	データなし	データなし
Christian Page	Member of Energy Advisory Board	2.7yrs	データなし	データなし

3.0yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: ADOの取締役会は経験豊富であると考えられます ( 3年の平均在任期間)。

AnteoTech マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

AnteoTech Limited, Annual General Meeting, May 28, 2024

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer

AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors

Board Member exercised options to buy AU$70k worth of stock.

Recent updates

New major risk - Financial position

Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023)

AnteoTech Limited to Report Fiscal Year 2024 Results on Aug 28, 2024

New minor risk - Share price stability

AnteoTech Limited, Annual General Meeting, May 28, 2024

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.

AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.

We're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

New minor risk - Financial data availability

Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer

AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023

New major risk - Share price stability

AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors

Will AnteoTech (ASX:ADO) Spend Its Cash Wisely?

Board Member exercised options to buy AU$70k worth of stock.

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023

Non-Executive Director recently sold AU$61k worth of stock

Is AnteoTech (ASX:ADO) In A Good Position To Invest In Growth?

High number of new and inexperienced directors

AnteoTech Ltd Announces Halt of European Rat Clinical Trial to Refocus Initiatives

AnteoTech Limited Appoint Executives

Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021)

AnteoTech Limited, Annual General Meeting, Nov 17, 2022

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

AnteoTech Limited Appoints David Radford as Managing Director, Effective from 4 October 2022

AnteoTech Limited SHS to Be Deleted from OTC Equity

Non-Executive Director recently sold AU$106k worth of stock

AnteoTech Ltd Announces Updated COVID-19 RAT Receives Regulatory Approval in Europe

Non-Executive Director recently sold AU$220k worth of stock

High number of new and inexperienced directors

AnteoTech Limited Announces Executive Changes

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

Non-Executive Director recently sold AU$108k worth of stock

Company Secretary Duncan Cornish has left the company

High number of new and inexperienced directors

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

High number of new and inexperienced directors

Independent Non-Executive Director recently bought AU$59k worth of stock

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020)

Chief Financial Officer Gail Jukes has left the company

Non-Executive Director recently sold AU$112k worth of stock

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 12.000001 million.

AnteoTech Limited announced that it expects to receive AUD 12.000001 million in funding

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

Independent Non-Executive Director has left the company

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

New 90-day high: AU$0.21

AnteoTech Customer Ellume Secures Us Contract

We're Not Very Worried About AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Progresses COVID-19 Test Toward Market Launch

AnteoTech Ltd Freeze Design of COVID-19 Antigen Rapid Test After Showing Saliva Proxy Sample Use Case Effectiveness

Independent Non-Executive Director exercised options to buy AU$208k worth of stock.

Full year earnings released - AU$0.002 loss per share

CEO報酬分析

CEO（最高経営責任者

在職期間

マネジメント基準チェック /14